b-One

Medical Devices & EquipmentSeries BBeijing, Chinacn.b1.co

Latest round

Series B

Last raised

Dec 2022

Total raised

Undisclosed

Investors

5

About b-One

Established in 2017 and based in Beijing, China, b-One is a medical device company that focuses on development of joint prosthesis products. Mark Kester, PhD, the company’s chief scientist, is the former global senior research director of Stryker. Imants Liepins, the company’s senior R&D director is the former R&D director of ZimmerBiomet and Stryker. The company has branches in Shanghai, Suzhou and Bristol. By 2022, b-One has about 200 employees. The company's main products are joint prosthesis products, including total knee system, femoral hip system and primary acetabular system. It also provides a limb salvage plan for bone tumors, including pelvic side, femur, tibia, calcaneus and talus, humerus, scapula, finger, radius and ulna and other limb bones.

Who invested in b-One

5 investors across 3 rounds

See all investors in b-One

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 28, 2022

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Apr 2, 2021

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Apr 26, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about b-One

Who invested in b-One?

b-One has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has b-One raised?

b-One has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did b-One last raise money?

b-One's most recent round on record is a Series B, in Dec 2022.

What does b-One do?

Established in 2017 and based in Beijing, China, b-One is a medical device company that focuses on development of joint prosthesis products.

Where is b-One headquartered?

b-One is headquartered in Beijing, China.

Which VCs invest in companies like b-One?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at b-One's stage. Their profiles are linked below.

Raising like b-One? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.